Pharmacology of Traumatic Brain Injury: Where Is the "Golden Bullet"?

Review Article

Kathryn Beauchamp, Haitham Mutlak, Wade R Smith, Esther Shohami, and Philip F Stahel


Traumatic bran injury (TBI) – a major health care problem and significant socioeconomic challenge – is the leading cause of death and disability in young people.  Approximately 1.5 million patients in the United States are affected each year, and despite advances in research and improved neurointensive care, no specific pharmacological therapy for TBI patients is currently available.  Beauchamp et al. review the published prospective clinical trials on pharmacological treatment modalities for TBI patients and outline future promising therapeutic options in the field.

View article: PDF


Posted by Leah Caracappa on Dec 4, 2008 12:00 AM CST